Nuvalent, INC. (NUVL) SEC Filings — 2024
23 SEC filings for Nuvalent, INC. (NUVL) in 2024.
Filings
- Nuvalent Files 8-K on Executive Changes and Financials — 8-K · Dec 9, 2024
- Nuvalent, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Nuvalent, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Nuvalent Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Nuvalent, INC. SC 13G Filing — SC 13G · Nov 8, 2024
- Nuvalent, INC. SC 13G Filing — SC 13G · Oct 24, 2024
- Nuvalent Enters Material Definitive Agreement — 8-K · Sep 17, 2024
- Nuvalent Files 8-K: Other Events & Financials — 8-K · Sep 16, 2024
- Nuvalent Files 10-Q: Financials and Equity Details — 10-Q · Aug 8, 2024
- Nuvalent Appoints Dr. Arvind Sood as Chief Medical Officer — 8-K · Jul 22, 2024
- Nuvalent Files 8-K on Shareholder Vote Matters — 8-K · Jun 14, 2024
- Nuvalent Appoints New Chief Medical Officer — 8-K · May 16, 2024
- Nuvalent, INC. SC 13G/A Filing — SC 13G/A · May 15, 2024
- Nuvalent, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Nuvalent, Inc. Announces 2024 Annual Meeting of Stockholders on June 12, 2024 — DEF 14A · Apr 26, 2024
- Bain Capital Life Sciences Amends Nuvalent Stake — SC 13D/A · Mar 29, 2024
- Nuvalent, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Nuvalent, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Nuvalent, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Deerfield Management Updates Nuvalent Stake in SC 13G/A Filing — SC 13G/A · Feb 12, 2024
- FMR LLC & Abigail Johnson Hold 14.942% Stake in Nuvalent Inc. — SC 13G/A · Feb 9, 2024
- Nuvalent 8-K Signals Update on Financial Condition — 8-K · Jan 9, 2024
- Perceptive Advisors Discloses 5.0% Stake in Nuvalent (NUVL) — SC 13G · Jan 2, 2024